Product Description
The Colombian dental bone graft substitute and other biomaterials market was valued at $73 million in 2024. This is expected to increase over the forecast period at a CAGR of 14.3% to reach nearly $186 million by 2031.
The full report suite on the Colombian market for dental bone graft substitute (DBGS) and other biomaterials includes DBGSs, dental barrier membranes, local antimicrobial periodontal treatments and dental soft tissue repair. Collectively, these segments will be referred to as the dental biomaterials market.
MARKET DATA INCLUDED
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- Procedure Numbers
- Market Drivers & Limiters
- Market Forecasts Until 2031, and Historical Data to 2021
- Recent Mergers & Acquisitions
- Company Profiles and Product Portfolios
- Leading Competitors
COLOMBIAN DENTAL BONE GRAFT SUBSTITUTE MARKET TRENDS
Market growth is expected to be driven by ongoing technological advancements that enable the introduction of innovative products aimed at improving ease of use and enhancing patient comfort. New product launches not only broaden a company’s portfolio but also help capture a greater share of the market, particularly in innovation-driven segments such as the dental barrier membrane market. These innovations often support stable or increasing ASPs, thereby contributing to overall market value growth. Furthermore, as additional clinical research continues to validate the efficacy of advanced biomaterials, the adoption of next-generation dental regenerative products is anticipated to accelerate.
COLOMBIAN DENTAL BONE GRAFT SUBSTITUTE MARKET SHARE INSIGHTS
- ZimVie, formerly known as Zimmer Biomet, was the leading competitor in the total dental biomaterials market in 2024. The company maintained its top position by offering a comprehensive range of products across all sub-segments of the market. In Colombia, ZimVie’s Puros® line held a dominant share of the allograft segment. Additionally, ZimVie provides pericardium membranes under its Puros® and CopiOs® brands, as well as collagen membranes under its BioMend®, CopiOs® and OsseoGuard® lines. The company’s broad and trusted portfolio has enabled it to capture consistent growth across key market segments, a trend that is expected to continue throughout the forecast period.
- Henry Schein expanded its global dental biomaterials portfolio through the acquisition of BioHorizons, a mid-sized company that has experienced significant growth in both dental implant sales and regenerative solutions. In 2024, BioHorizons emerged as the second-leading competitor in Colombia’s overall dental biomaterials market, driven by the continued success of its dental regenerative product lines. Its DBGS offerings include MinerOss®, Grafton® DBM and LADDEC®, which are products originally developed by Osteotech. The MinerOss® portfolio includes a variety of allograft options such as cortical, cancellous and composite grafts, which serve as osteoconductive scaffolds across a wide range of clinical applications. The acquisition has allowed Henry Schein to strengthen its competitive standing in the Colombian market by incorporating BioHorizons’ established biomaterials into its broader suite of implant and regenerative solutions.
- 3Biomat, a Colombian-based medical device manufacturer, holds the third-largest share in the country’s DBGS market in 2024. The company’s portfolio includes a range of xenograft-based products and collagen membranes designed for guided bone regeneration (GBR) procedures. Notably, 3Biomat’s Biomec Cx collagen membrane is utilized in various regenerative treatments, including sinus lifts and ridge augmentations.
MARKET SEGMENTATION SUMMARY
- Dental Bone Graft Substitutes – Further Segmented Into:
- Type: Allografts, Xenografts, and Synthetics.
- Dental Barrier Membranes – Further Segmented Into:
- Type: Resorbable and Non-Resorbable Membranes.
- Material: Xenografts, Synthetics, and Allografts.
- Antimicrobial Periodontal Treatment
- Dental Soft Tissue Wound Care – Further Segmented Into:
- Type: Plugs, Tape, and Foam.
RESEARCH SCOPE SUMMARY
| Report Attribute | Details |
|---|---|
| Regions | Colombia |
| Base Year | 2024 |
| Forecast Period | 2025-2031 |
| Historical Data | 2021-2023 |
| Quantitative Data | Procedure Numbers, Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices. |
| Qualitative Data | Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews. |
| Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |
CONTACT US FOR ADDITIONAL INFORMATION
For full segmentation and any questions regarding research coverage, please contact us for a complimentary demo of the full report.
